Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 302 followers
Latest posts
Last updated about 2 hours ago
Trump administration faces mounting litigation as 16 states sue over NIH grant cuts
about 2 hours ago
Sixteen state attorneys general are suing the Department of Health and Human...
Brown University set to have $510M in federal research grants frozen: reports
about 2 hours ago
Brown University has become the fifth university to be targeted by the...
Resmed debuts wearable, at-home sleep apnea test
about 4 hours ago
The NightOwl, about the size of a quarter, is worn on the...
Relay Therapeutics starts third layoff wave in 1 year, shedding 70 staffers
about 5 hours ago
Relay Therapeutics has laid off about 70 employees, the biotech's third round...
F-star charts new path, splitting from invoX after 2023’s $161M acquisition
about 6 hours ago
After a drawn-out acquisition that closed in 2023, U.K. biotech F-star Therapeutics...
A closer look at pharma's top R&D budgets
about 7 hours ago
This week on "The Top Line," we dive into our special report...
Servier severing forces OPM to make 'drastic choices' to adapt as it cuts staff, executive wages
about 8 hours ago
Servier’s decision to exit a Parkinson’s disease pact has triggered belt tightening...
Chutes & Ladders—FDA rocked by leadership shake-ups
about 8 hours ago
As the Department of Health and Human Services grapples with the fallout...
Apollomics tags out of TYG oncology pact to cut costs, extend runway into 2026
about 10 hours ago
Apollomics has tagged out of its partnership with TYG Oncology, terminating an...
Shuren on FDA's future: 'Where do we go from here? ... Who knows?'
about 10 hours ago
In a webinar hosted by the medtech development service provider NAMSA, the...
Eli Lilly helps struggling Sangamo with $1.4B gene therapy deal
about 23 hours ago
Sangamo Therapeutics has secured a licensing deal with Eli Lilly that helps...
Cell therapy biotech Neurona nabs $102M to push epilepsy candidate into phase 3
1 day ago
The California biotech will use the cash infusion to support its pipeline...